Healthium Medtech and C-CAMP Roll Out Medical Innovation Cohort in India

Healthium Medtech along with the Centre for Cellular and Molecular Platforms (C-CAMP) has announced the very first group of the C-CAMP Healthium Innovations Programme

Piramal Pharma, NewAmsterdam Open Oral Solid Dosage Suite in Sellersville

Piramal Pharma Solutions (PPS), a prominent international Contract Development and Manufacturing Organization (CDMO) and member of Piramal Pharma Ltd.

Takeda Pharma Plans to Launch Clinical Trials in India Soon

Takeda Pharmaceuticals, a Japanese drug manufacturer, is expanding its presence in India by looking into ways to conduct global clinical trials there.

Dr. Lal PathLabs First in India to Use AI for Cancer Diagnosis

India is experiencing a revolution in the diagnostic industry with Dr. Lal PathLabs becoming the first lab in the country to utilize deep learning based artificial intelligence module to detect lymph node metastasis including micro-metastasis in pati

DavaIndia Set to Expand Nationwide With Tech-Driven Growth

In the next years, DavaIndia, a private generic pharmacy retail chain owned by Gujarat-based Zota Healthcare, plans to grow from its existing 1,600 locations to over 3,000

AnGes, Boehringer Partner to Develop PAD Drug Ingredient

A contract development and manufacturing agreement has been signed between AnGes Inc. and Boehringer Ingelheim, a biopharmaceutical business involved in both human and animal health, for the drug ingredient of AnGes' experimental treatment for

P D Hinduja Hospital and Medical Research Centre Launches First of its Kind Dedicated Geriatric Clinic on World Senior Citizen Day 2025

On the occasion of World Senior Citizen’s Day 2025, P. D. Hinduja Hospital & Medical Research Centre today inaugurated its first-of-its-kind dedicated Geriatric Clinic committed to providing comprehensive care for senior citizens

NATCO Pharma Launches Bosentan Oral Suspension in US with 180-Day Edge

NATCO Pharma Limited has announced the launch of Bosentan tablets for oral suspension (TFOS), 32 mg, in the United States.

Pharma Compliance Software 2025 :Smarter Solutions for Regulatory Success

Pharma compliance software is significant for Pharmaceutical regulations, and it set to become newer and more complex in 2025. Many companies are adopting advanced compliance software to help streamline compliance gained by multilayered requirements

Foxconn Invests in Robocore Ahead of Planned IPO

Robocore Technology Limited (Robocore), a member of the Hong Kong Science and Technology Parks Corporation (HKSTP) Partner Programme, announced that it has recently completed its Series D funding

on the deck

Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.